Table 4 Body weight, serum glucose level, lipid profile, liver and kidney functions in control and obese groups without ZnSO₄ tretatment, low dose (15 mg) ZnSO₄ treatment, and high dose (30 mg) ZnSO₄ treatment in female rats.

Body weight (g)

215.6 ± 11.4^d

209.8 ± 14.8^d

205.6 ± 8.8^de

331.4 ± 16.3^b

189.1 ± 7.2^de

178.3 ± 30.5^e

Glucose (mg/dl)

83.0 ± 14.5^d

89.6 ± 3.0^cd

93.7 ± 9.0^cd

132.2 ± 11.0^a

105.0 ± 9.8^b

95.8 ± 5.2^bc

Lipid profile

 Lipids (mg/dl)

256.0 ± 11.8^ef

232.4 ± 17.7^f

237.4 ± 29.2^f

307.2 ± 18.4^cd

283.2 ± 36.3^de

281.7 ± 40.5^de

 Cholesterol (mg/dl)

69.1 ± 12.1^de

58.3 ± 8.8^e

54.3 ± 10.3^e

102.6 ± 8.4^bc

81.2 ± 9.1^cd

82.7 ± 25.6^cd

 Triglyceride (mg/dl)

149.0 ± 17.5^b

146.7 ± 5.1^b

141.2 ± 23.0^b

218.7 ± 27.8^a

153.7 ± 20.3^b

160.2 ± 6.9^b

Liver enzymes

 GOT (U/L)

142.8 ± 23.4^cdef

111.0 ± 25.0^f

128.4 ± 29.0^ef

154.8 ± 15.8^cde

133.1 ± 15.6^def

128.8 ± 21.2^ef

 GPT (U/L)

31.8 ± 4.0^gh

27.6 ± 4.6 ^h

30.2 ± 5.3^gh

51.6 ± 7.9^c

35.92 ± 4.4 ^fg

35.6 ± 3.3 ^fg

Kidney functions

 Urea (mg/dl)

34.4 ± 1.3^de

35.7 ± 3^.0^cde

36.4 ± 2.3^cde

41.1 ± 4.5^a

36.2 ± 3.6^cde

36.9 ± 3.1^cde

 Uric acid (mg/dl)

3.6 ± 0.3^cd

3.7 ± 0.3^cd

3.8 ± 0.3^bc

4.5 ± 1.3bs

3.7 ± 0.4^cd

3.7 ± 0.5^cd

 Creatinine (mg/dl)

0.6 ± 0.02^ab

0.6 ± 0.09^ab

0.6 ± 0.08^ab

0.5 ± 0.08^b

0.6 ± 0.08^ab

0.5 ± 0.07^b